H. Lundbeck, new study highlights positive effect of Ebixa® on brain activity

The results of a randomised, placebo-controlled PET (positron emission tomography) imaging pilot study designed to measure the effect Ebixa®  (memantine) has on functional brain activity in patients with mild to moderate Alzheimer’s disease were announced today.